FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and represents a method for active substance delivery to a patient in need thereof, involving: active substance selection, wherein the active substance is degraded in a body of said patients in the oral, subcutaneous or intravenous introduction and wherein the efficacy of said active substance is reduced as a result of said degradation; said active substance is not GLP-1; combination of said active substance and diketopiperazine to prepare a pharmaceutical composition applicable for pulmonary inhalation; and introduction of said pharmaceutical composition into said patient.
EFFECT: invention presents the drug delivery system which prevents deactivation or degradation of the active substance introduced into the patient in need thereof.
19 cl, 8 ex, 6 tbl, 19 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE (GLP-1) | 2007 |
|
RU2409349C2 |
| PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE 1 (GLP-1) | 2007 |
|
RU2542500C2 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUGS DELIVERY | 2011 |
|
RU2531455C2 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
| DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
| METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT | 2007 |
|
RU2403059C2 |
| DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS | 2010 |
|
RU2490026C1 |
| APPLICATION OF SUPERFAST-ACTING INSULIN | 2009 |
|
RU2519706C2 |
| USE OF SUPER-HIGH-SPEED INSULIN | 2014 |
|
RU2688663C2 |
